Carsten Brunn, President and CEO at Cartesian Therapeutics, Inc. (RNAC), sold 34,542 shares at $16.72 ($579K) on 2025-01-03, disclosed to the SEC on 2025-01-07.
Open-market sale of $579k RNAC by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.72 | 8,563 | $143K | 24.7% |
| 2 | $16.72 | 8,563 | $143K | 24.7% |
| 3 | $16.83 | 8,708 | $147K | 25.3% |
| 4 | $16.83 | 8,708 | $147K | 25.3% |
| Total | $16.78 avg | 34,542 | $579K | 100% |
| Filing → |
| SELB | SELL | 2023-01-06 | $46K | — | Filing → |
| SELB | SELL | 2022-12-07 | $6K | — | Filing → |
| SELB | SELL | 2022-09-30 | $4K | — | Filing → |